The company's products span nine areas of women's health, including mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia (excessive periods), permanent contraception, osteoporosis assessment, preterm birth risk assessment and mini C-arms for extremity imaging, as well as molecular diagnostic products, including human papillomavirus (HPV) testing and reagents for a variety of DNA and RNA analysis applications.

"We have the strength and resources of a billion dollar company, along with the vision of leaders committed to a broad spectrum of women's health issues," Culley said. "Our nearly 4,000 employees are personally dedicated to achieving breakthroughs in research, product development and the worldwide distribution of healthcare solutions. And we have the unwavering partnerships of thousands of healthcare professionals who match our dedication to extending and enriching the lives of women everywhere."

Back to HCB News

More Voices